An interesting interaction pattern has been found between HIV-1 and GBV-C/HGV, resulting in protection against progression to AIDS. The mechanisms involved in this interaction remain to be clarified. We examined the current knowledge concerning this coinfection and developed hypotheses to explain its effects. A better understanding of this interaction could result in new concepts, which may lead to new strategies to control HIV-1 replication and progression to AIDS
A strategy for antiviral drug discovery is the elucidation and imitation of viral interference mecha...
The antiherpes drug acyclovir was found to inhibit HIV following its phosphorylation by human herpes...
To determine whether GB virus C (GBV-C) infection is as-sociated with protection against vertical tr...
An interesting interaction pattern has been found between HIV-1 and GBV-C/HGV, resulting in protecti...
GB virus C (GBV-C) and hepatitis G virus (HGV) are two isolates of the same virus, independently ide...
Background: GB virus type C (GBV-C) co-infection prolongs survival among Human Immunodeficiency Viru...
Increasing clinical evidence is emerging that other persistent viral infections can act as important...
Background. An association between GB virus C (GBV-C) and improved outcomes of human immunodeficien-...
In 1995 the GB virus C (GBV-C) was identified. Although it is related to the hepatitis C virus, ther...
The GB virus C or hepatitis G virus (GBV-C/HGV) is a single-stranded positive sense RNA virus that b...
GB virus C (GBV-C), an RNA virus closely related to hepatitis C virus (HCV), is transmitted through ...
The prognostic role of GB virus type C (GBV-C) viraemia in HIV-infected subjects treated with highly...
Introduction: Infection with the human immunodeficiency virus (HIV) can result in severe immune supp...
Herpes simplex virus types 1 and 2 (HSV-1 and -2) are two of the major opportunistic agents involved...
Recent proof-of-concept randomised controlled trials have shown a causal relation between herpes sim...
A strategy for antiviral drug discovery is the elucidation and imitation of viral interference mecha...
The antiherpes drug acyclovir was found to inhibit HIV following its phosphorylation by human herpes...
To determine whether GB virus C (GBV-C) infection is as-sociated with protection against vertical tr...
An interesting interaction pattern has been found between HIV-1 and GBV-C/HGV, resulting in protecti...
GB virus C (GBV-C) and hepatitis G virus (HGV) are two isolates of the same virus, independently ide...
Background: GB virus type C (GBV-C) co-infection prolongs survival among Human Immunodeficiency Viru...
Increasing clinical evidence is emerging that other persistent viral infections can act as important...
Background. An association between GB virus C (GBV-C) and improved outcomes of human immunodeficien-...
In 1995 the GB virus C (GBV-C) was identified. Although it is related to the hepatitis C virus, ther...
The GB virus C or hepatitis G virus (GBV-C/HGV) is a single-stranded positive sense RNA virus that b...
GB virus C (GBV-C), an RNA virus closely related to hepatitis C virus (HCV), is transmitted through ...
The prognostic role of GB virus type C (GBV-C) viraemia in HIV-infected subjects treated with highly...
Introduction: Infection with the human immunodeficiency virus (HIV) can result in severe immune supp...
Herpes simplex virus types 1 and 2 (HSV-1 and -2) are two of the major opportunistic agents involved...
Recent proof-of-concept randomised controlled trials have shown a causal relation between herpes sim...
A strategy for antiviral drug discovery is the elucidation and imitation of viral interference mecha...
The antiherpes drug acyclovir was found to inhibit HIV following its phosphorylation by human herpes...
To determine whether GB virus C (GBV-C) infection is as-sociated with protection against vertical tr...